These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1355703)

  • 1. Tay-Sachs disease as a model for screening inborn errors.
    Blitzer MG; McDowell GA
    Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
    Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
    N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
    JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience.
    Kaback MM
    Prog Clin Biol Res; 1982; 103 Pt B():447-59. PubMed ID: 7163239
    [No Abstract]   [Full Text] [Related]  

  • 13. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.
    Park NJ; Morgan C; Sharma R; Li Y; Lobo RM; Redman JB; Salazar D; Sun W; Neidich JA; Strom CM
    Pediatr Res; 2010 Feb; 67(2):217-20. PubMed ID: 19858779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method.
    Tamasu S; Nishio H; Ayaki H; Lee MJ; Mizutori M; Takeshima Y; Nakamura H; Matsuo M; Maruo T; Sumino K
    Kobe J Med Sci; 1999 Dec; 45(6):259-70. PubMed ID: 10985159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inborn errors of lysosomal catabolism--principles of heterozygote detection.
    Jolly RD; Desnick RJ
    Am J Med Genet; 1979; 4(3):293-307. PubMed ID: 117711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.